 Clofarabine is a drug approved by the FDA Food and Drug Administration for treating children age 1-21 with leukemia. This research study will use clofarabine with two other cancer fighting drugs. Clofarabine will be used together with etoposide VePesid, VP-16 and cyclophosphamide Cytoxan. 